- Home
- OMIC vs ICAD Comparison
OMIC vs ICAD Comparison
Compare OMIC & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- ICAD
- Stock Information
- Founded
- OMIC 2016
- ICAD 1984
- Country
- OMIC United States
- ICAD United States
- Employees
- OMIC 127
- ICAD N/A
- Industry
- OMIC Medical/Dental Instruments
- ICAD Medical/Dental Instruments
- Sector
- OMIC Health Care
- ICAD Health Care
- Exchange
- OMIC Nasdaq
- ICAD Nasdaq
- Market Cap
- OMIC 49.9M
- ICAD 40.8M
- IPO Year
- OMIC 2021
- ICAD 1986
- Fundamental
- Price
- OMIC $19.70
- ICAD $1.97
- Analyst Decision
- OMIC Hold
- ICAD
- Analyst Count
- OMIC 2
- ICAD 0
- Target Price
- OMIC $10.75
- ICAD N/A
- AVG Volume (30 Days)
- OMIC 21.3K
- ICAD 196.3K
- Earning Date
- OMIC 11-12-2024
- ICAD 03-11-2025
- Dividend Yield
- OMIC N/A
- ICAD N/A
- EPS Growth
- OMIC N/A
- ICAD N/A
- EPS
- OMIC N/A
- ICAD N/A
- Revenue
- OMIC $2,667,000.00
- ICAD $18,940,000.00
- Revenue This Year
- OMIC $0.82
- ICAD $10.15
- Revenue Next Year
- OMIC $252.64
- ICAD $3.75
- P/E Ratio
- OMIC N/A
- ICAD N/A
- Revenue Growth
- OMIC 2.77
- ICAD 10.03
- 52 Week Low
- OMIC $5.34
- ICAD $1.18
- 52 Week High
- OMIC $23.41
- ICAD $2.65
- Technical
- Relative Strength Index (RSI)
- OMIC 48.55
- ICAD 54.41
- Support Level
- OMIC $19.25
- ICAD $1.81
- Resistance Level
- OMIC $19.90
- ICAD $2.04
- Average True Range (ATR)
- OMIC 0.32
- ICAD 0.14
- MACD
- OMIC 0.02
- ICAD -0.01
- Stochastic Oscillator
- OMIC 54.55
- ICAD 53.75
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.